Examples of Recent Oncology Market Research Studies
Quantitative model-based messaging research:
The research utilized novel TURF and Tournament-Based Conjoint Modeling approaches developed in our in-house R&D program. We aided our client in developing the most impactful way of communicating clinical trial results in the area of renal cell carcinoma, and how best to customize messaging to different oncologist segments
Qualitative and quantitative research that identified high opportunity segments within the overall breast cancer oncology community. The research combined both marketing- and sales objectives to create a segmentation framework that both sets of stakeholders were able to use and implement.
Two-phase qualitative positioning research in the US, EU and Asia. Study identified a positioning platform that is compelling, credible and sustainable across markets and multiple indications.
Qualitative Research with KOLs and community oncologists:
Assessment of the viability of a secondary indication in Breast Cancer for a new medication in development. The study provided strategic insight around the market and treatment options for metastatic HER2+ breast cancer and the degree of incremental efficacy or safety benefit required for adoption of a number of medications currently in the Breast Cancer pipeline. We provided recommendations on how to leverage physician beliefs of where different treatment regimens may fit in the future; including their interest in using a new class of oncology agent in an already crowded breast cancer market
Qualitative Research with Nurses / Nurse Practitioners:
Research with nurse practitioners and chemotherapy nurses in the US and EU provided insight for our client in how best to work with nurses in their role in communicating therapy options and provision of support to patients.
Observant LLC | 1601 Trapelo Road, Suite 255 | Waltham, MA 02451 | 781.642.0644 | info@observant.biz